NMRA vs TWLO · $283.5M cap vs P/E 1087, rev $4.46B
Neumora Therapeutics, Inc. (NMRA) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
NMRA currently screens at market cap $283.5M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the NMRA and TWLO stock pages for the full models.
Not investment advice.